# Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study

> **NCT05574894** · PHASE3 · COMPLETED · sponsor: **ShangHai Ji Ai Genetics & IVF Institute** · enrollment: 692 (actual)

## Conditions studied

- Growth Hormone
- Advanced Maternal Age
- PGT-A

## Interventions

- **DRUG:** Growth hormone
- **DRUG:** GnRH antagonist

## Key facts

- **NCT ID:** NCT05574894
- **Lead sponsor:** ShangHai Ji Ai Genetics & IVF Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 692 (ACTUAL)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05574894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05574894, "Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05574894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*